News
Feed
Events
Feed
News
+ Events
Feed

SCHOTT Pharma AG & Co. KGaA

  • ISIN DE000A3ENQ51
  • Country Deutschland

Latest Reports

27 June 2024

Quarterly Report PDF

SCHOTT Pharma AG & Co. KGaA

Quarterly Report
PDF

Half-yearly financial report 2023/2024

Presentation DE PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
DE
PDF

Präsentation H1 2023/2024 (englisch)

Presentation PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
PDF

Presentation H1 2023/2024

15 March 2024

Corporate Governance PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
PDF

Remuneration Report 2022/2023

Corporate Governance DE PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
DE
PDF

Vergütungsbericht 2022/2023

14 March 2024

Corporate Governance DE PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
DE
PDF

Vergütungssystem für die Mitglieder des Vorstands der persönlich haftenden Gesellschafterin

Corporate Governance DE PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
DE
PDF

Vergütungssystem für die Mitglieder des Aufsichtsrats

Corporate Governance PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
PDF

Remuneration System for the Members of the Management Board of the personally liable partner

Corporate Governance PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
PDF

Remuneration System for the Members of the Supervisory Board

29 February 2024

Presentation PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
PDF

Presentation Q1 2023/2024

Quarterly Report PDF

SCHOTT Pharma AG & Co. KGaA

Quarterly Report
PDF

Q1 statement / Q1 financial report 2023/2024

Presentation DE PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
DE
PDF

Präsentation Q1 2023/2024 (englisch)

26 January 2024

Online Annual Report

SCHOTT Pharma AG & Co. KGaA

Online Annual Report

Conference Call for FY 2022/2023

Online Annual Report DE

SCHOTT Pharma AG & Co. KGaA

Online Annual Report
DE

Konferenz zum Geschäftsjahr 2022/2023

Annual Report PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
PDF

Sustainability Report 2022/2023

Presentation DE PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
DE
PDF

SCHOTT Pharma 2023 Präsentation (englisch)

Presentation PDF

SCHOTT Pharma AG & Co. KGaA

Presentation
PDF

SCHOTT Pharma 2023 Presentation

Annual Report PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
PDF

Financial Statement of SCHOTT Pharma AG & Co. KGaA (HGB) 2022/2023

Annual Report

SCHOTT Pharma AG & Co. KGaA

Annual Report

Annual Report 2022/2023 (Online)

Annual Report DE

SCHOTT Pharma AG & Co. KGaA

Annual Report
DE

Geschäftsbericht 2022/2023 (Online)

Annual Report DE PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
DE
PDF

Jahresfinanzbericht 2022/2023 (PDF)

Annual Report DE ZIP

SCHOTT Pharma AG & Co. KGaA

Annual Report
DE
ZIP

Jahresfinanzbericht 2022/2023 (ZIP)

Annual Report PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
PDF

Annual financial report 2022/2023 (PDF)

Annual Report DE PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
DE
PDF

Nachhaltigkeitsbericht 2022/23 (englisch)

Annual Report DE PDF

SCHOTT Pharma AG & Co. KGaA

Annual Report
DE
PDF

Jahresabschluss der SCHOTT AG & Co. KGaA (HGB) 2022/2023

18 December 2023

Corporate Governance DE PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
DE
PDF

2023 Dezember Erklärung zur Unternehmensführung

Corporate Governance PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
PDF

2023 December Declarations of Corporate Governance (german)

15 December 2023

Corporate Governance DE PDF

SCHOTT Pharma AG & Co. KGaA

Corporate Governance
DE
PDF

2023 Dezember Entprechenserklärung

Upcoming Events

29

Aug 24

SCHOTT Pharma AG & Co. KGaA

Publication quarterly statement (call-date Q3)

12

Dec 24

SCHOTT Pharma AG & Co. KGaA

Publication annual financial report

04

Feb 25

SCHOTT Pharma AG & Co. KGaA

Annual General Meeting

13

Feb 25

SCHOTT Pharma AG & Co. KGaA

Publication quarterly statement (call-date Q1)

15

May 25

SCHOTT Pharma AG & Co. KGaA

Publication half-yearly financial report

12

Aug 25

SCHOTT Pharma AG & Co. KGaA

Publication quarterly statement (call-date Q3)